JAMA Editor’s Summary

Heterogeneity in Blood Pressure Response to Antihypertensive Drugs, Renin-Angiotensin System Modulation for COVID-19, Review of Prediabetes, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 11, 2023, issue. Related Content:

April 11, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Coordinated Care to Optimize Treatment in Patients With Diabetes and Cardiovascular Disease, Panitumumab vs Bevacizumab Added to Chemotherapy for Metastatic Colorectal Cancer, USPSTF Recommendation on Screening for Skin Cancer, and more

← Older

Statin Treatment Strategies for Patients With Coronary Artery Disease, Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19, Review of Diagnosis and Treatment of Acute Myocarditis, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Heterogeneity in Blood Pressure Response to Antihypertensive Drugs, Renin-Angiotensin System Modulation for COVID-19, Review of Prediabetes, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 11, 2023, issue. Related Content: